Pathway
Vedolizumab therapy for inflammatory bowel disease
WP:5512
What the reference databases state
Statements
10 statements
10 statements · 1 reference database · Subject: Vedolizumab therapy for inflammatory bowel disease · Sources: WikiPathways
- ICAM1 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- ITGA2 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- ITGA4 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- ITGB1 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- ITGB2 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- ITGB7 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- MADCAM1 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- SELE participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- SELPLG participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only
- VCAM1 participates in Vedolizumab therapy for inflammatory bowel diseaseProteinWikiPathways WP5512Inferred only